Back to User profile » Dr Mathias Schulz

Papers published by Dr Mathias Schulz:

Original Research

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI

Lung Cancer: Targets and Therapy 2019, 10:125-130

Published Date: 13 November 2019

Original Research

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

DiBonaventura MD, Wong W, Shah-Manek B, Schulz M

OncoTargets and Therapy 2018, 11:75-82

Published Date: 22 December 2017